Actively Recruiting
Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia
Led by Groupe Francophone des Myelodysplasies · Updated on 2025-05-06
6990
Participants Needed
1
Research Sites
1434 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Registry MDS is an ongoing, observational study that has collected longitudinal data on diagnostics, demographics, clinical parameters, and health Care Interventions (HCI) from patients with MDS and therapy-related acute myeloid leukemia
CONDITIONS
Official Title
Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female
- Age greater than 18 years
- Diagnosed with myelodysplastic syndrome or therapy-related acute myeloid leukemia
- Able and willing to provide written informed consent
You will not qualify if you...
- Age less than 18 years
- Unwilling or unable to give consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Aspasia Stamatoullas
Rouen, France, 76038
Actively Recruiting
Research Team
F
Fatiha CHERMAT, PhD
CONTACT
P
Pierre FENAUX, Pr
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here